Melasma. Diseases of the Skin and Subcutaneous Tissue
Conditions
Interventions
Intervention group:The intervention Group Includes 45 Patients between the ages of 18 and 60 with Melasma. At the Beginning of the Study, for each Patient, in addition to Demographic information, incl
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: People Aged 18 to 60 with a Diagnosis of Melasma
Exclusion criteria
Exclusion criteria: Any Melasma Treatment within the 1 Month ago Having Contraindications for the Use of Tranexamic Acid Having Psychiatric Diseases that May Affect the Study Process Lack of Informed Consent to Participate in the Study No Possibility of Regular Visit and Follow-up Having an Underlying Disease Related to Melasma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melasma Severity based on Melasma Score. Timepoint: Three sessions of Mesotherapy with an Ampoule of Tranexamic Acid are Performed at the Melasma Site with an interval of Two Weeks, and the Patient is Evaluated 2 weeks after the Completion of the Treatment. Method of measurement: Modified Melasma Area and Severity Index.;Melasma. Timepoint: Three sessions of Mesotherapy with an Ampoule of Tranexamic Acid are Performed at the Melasma Site with an interval of Two Weeks, and the Patient is Evaluated 2 weeks after the Completion of the Treatment. Method of measurement: Physician Global Assessment Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJangizahi Salman
Iran University of Medical Sciences
Outcome results
None listed